This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

- RBC Capital analyst Brian Abrahams upgraded **Neumora Therapeutics Inc** (NASDAQ: NMRA) from Sector Perform to Outperform and raised the price target from $4 to $7. Neumora Therapeutics shares closed at $2.24 on Friday. See how other analysts view this stock.
- BMO Capital analyst Fadi Chamoun upgraded **Old Dominion Freight Line Inc** (NASDAQ: ODFL) from Market Perform to Outperform and lowered the price target from $172 to $170. Old Dominion Freight Line shares closed at $135.29 on Friday. See how other analysts view this stock.
- BNP Paribas Exane analyst Thomas Poutrieux upgraded **Toast Inc** (NYSE: TOST) from Neutral to Outperform and announced a $40 price target. Toast shares closed at $34.19 on Friday. See how other analysts view this stock.
- HSBC analyst Kim Fustier upgraded **Chevron Corp** (NYSE: CVX) from Hold to Buy and raised the price target from $166 to $169. Chevron shares closed at $151.13 on Friday. See how other analysts view this stock.
- Jones Trading analyst Debanjana Chatterjee upgraded **Spyre Therapeutics Inc** (NASDAQ: SYRE) from Hold to Buy and announced a $64 price target. Spyre Therapeutics shares closed at $30.00 on Friday. See how other analysts view this stock.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>



<ul class="wp-block-list">
<li>RBC Capital analyst Brian Abrahams upgraded <strong>Neumora Therapeutics Inc</strong> <a href="https://www.benzinga.com/quote/NMRA" target="_blank" class="ticker-link" data-ticker="NMRA" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/NMRA">NMRA</a>)</a> from Sector Perform to Outperform and raised the price target from $4 to $7. Neumora Therapeutics shares closed at $2.24 on Friday. <a href="https://www.benzinga.com/quote/nmra/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>BMO Capital analyst Fadi Chamoun upgraded <strong>Old Dominion Freight Line Inc</strong> <a href="https://www.benzinga.com/quote/ODFL" target="_blank" class="ticker-link" data-ticker="ODFL" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ODFL">ODFL</a>)</a> from Market Perform to Outperform and lowered the price target from $172 to $170. Old Dominion Freight Line shares closed at $135.29 on Friday. <a href="https://www.benzinga.com/quote/ODFL/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>BNP Paribas Exane analyst Thomas Poutrieux upgraded <strong>Toast Inc</strong> <a href="https://www.benzinga.com/quote/TOST" target="_blank" class="ticker-link" data-ticker="TOST" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/TOST">TOST</a>)</a> from Neutral to Outperform and announced a $40 price target. Toast shares closed at $34.19 on Friday. <a href="https://www.benzinga.com/quote/TOST/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>HSBC analyst Kim Fustier upgraded <strong>Chevron Corp</strong> <a href="https://www.benzinga.com/quote/CVX" target="_blank" class="ticker-link" data-ticker="CVX" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/CVX">CVX</a>)</a> from Hold to Buy and raised the price target from $166 to $169. Chevron shares closed at $151.13 on Friday. <a href="https://www.benzinga.com/quote/CVX/analyst-ratings">See how other analysts view this stock</a>.</li>



<li>Jones Trading analyst Debanjana Chatterjee upgraded <strong>Spyre Therapeutics Inc</strong> <a href="https://www.benzinga.com/quote/SYRE" target="_blank" class="ticker-link" data-ticker="SYRE" data-exchange="NASDAQ">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SYRE">SYRE</a>)</a> from Hold to Buy and announced a $64 price target. Spyre Therapeutics shares closed at $30.00 on Friday. <a href="https://www.benzinga.com/quote/SYRE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>



<p>Considering buying CVX stock? Here&#8217;s what analysts think: </p>



<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/cvx/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="433" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01090003/image-16-1024x433.png" alt="" class="wp-image-1190784" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01090003/image-16-1024x433.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01090003/image-16-300x127.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01090003/image-16-768x325.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/01090003/image-16.png 1146w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>



<p><strong>Read This Next: </strong></p>



<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/dividends/25/11/49113168/wall-streets-most-accurate-analysts-weigh-in-on-3-financial-stocks-with-over-13-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 13% Dividend Yields</a></strong></li>
</ul>



<p>Photo via Shutetrstock</p>